1. Absolínová H, Jančář L, Jančářová I, Vičar J, Kubáň V (2009) Acid–base behaviour of sanguinarine and dihydrosanguinarine. Open Chem 7(4):876–883
2. Adhami VM, Aziz MH, Mukhtar H, Ahmad N (2003) Activation of prodeath Bcl-2 family proteins and mitochondrial apoptosis pathway by sanguinarine in immortalized human HaCaT keratinocytes. Clin Cancer Res 9(8):3176–3182
3. Adhami VM, Aziz MH, Reagan-Shaw SR, Nihal M, Mukhtar H, Ahmad N (2004) Sanguinarine causes cell cycle blockade and apoptosis of human prostate carcinoma cells via modulation of cyclin kinase inhibitor–cyclin–cyclin-dependent kinase machinery. Mol Cancer Ther 3(8):933–940
4. Ahmad N, Gupta S, Husain MM, Heiskanen KM, Mukhtar H (2000) Differential antiproliferative and apoptotic response of sanguinarine for cancer cells versus normal cells. Clin Cancer Res 6(4):1524–1528
5. Ansari KM, Das M (2010) Potentiation of tumour promotion by topical application of argemone oil/isolated sanguinarine alkaloid in a model of mouse skin carcinogenesis. Chem Biol Interact 188(3):591–597